HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nicoletta Schintu Selected Research

2- n- butyl- 9- methyl- 8- (1,2,3)triazol- 2- yl- 9H- purin- 6- ylamine

3/2011Neuroprotective and anti-inflammatory effects of the adenosine A(2A) receptor antagonist ST1535 in a MPTP mouse model of Parkinson's disease.
7/2007Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nicoletta Schintu Research Topics

Disease

9Parkinson Disease (Parkinson's Disease)
02/2013 - 07/2007
5Dyskinesias (Dyskinesia)
01/2020 - 07/2007
5Tremor (Tremors)
01/2020 - 07/2007
3Parkinsonian Disorders (Parkinsonism)
01/2020 - 10/2015
3Gliosis
03/2011 - 12/2009
2Neurodegenerative Diseases (Neurodegenerative Disease)
11/2019 - 03/2009
1Major Depressive Disorder (Major Depressive Disorders)
03/2017
1AIDS-Related Complex (ARC)
12/2014
1Animal Disease Models
11/2014
1Inflammation (Inflammations)
03/2009

Drug/Important Bio-Agent (IBA)

6Dopamine (Intropin)FDA LinkGeneric
02/2016 - 07/2008
5Tacrine (Cognex)FDA Link
01/2020 - 07/2007
5Levodopa (L Dopa)FDA LinkGeneric
01/2020 - 07/2007
3Pharmaceutical PreparationsIBA
11/2014 - 07/2007
31- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
03/2011 - 03/2009
3Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
03/2011 - 07/2007
2Cholinergic Agents (Cholinergics)IBA
11/2019 - 02/2016
2Neurotransmitter Agents (Neurotransmitter)IBA
11/2019 - 11/2014
2AMPA Receptors (AMPA Receptor)IBA
10/2015 - 12/2014
22- n- butyl- 9- methyl- 8- (1,2,3)triazol- 2- yl- 9H- purin- 6- ylamineIBA
03/2011 - 07/2007
1sarizotanIBA
01/2020
1Cholinesterase Inhibitors (Anticholinesterases)IBA
01/2020
1Acetylcholine (Acetylcholine Chloride)FDA Link
11/2019
1Antidepressive Agents (Antidepressants)IBA
03/2017
1Sirolimus (Rapamycin)FDA Link
02/2016
1AcetyltransferasesIBA
02/2016
1Therapeutic UsesIBA
02/2016
1RO5166017IBA
10/2015
1Trace amine-associated receptor 1IBA
10/2015
1Oxidopamine (6 Hydroxydopamine)IBA
10/2015
1AcidsIBA
12/2014
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
12/2014
1N-Methylaspartate (NMDA)IBA
12/2014
1Messenger RNA (mRNA)IBA
12/2014
1Transcription Factors (Transcription Factor)IBA
02/2013
1N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA
05/2010
18-ethoxy- 9-ethyladenineIBA
03/2010
1Adenosine (Adenocard)FDA LinkGeneric
12/2009
1Neuroprotective AgentsIBA
12/2009
15- amino- 7- (2- phenylethyl)- 2- (2- furyl)pyrazolo(4,3- e)- 1,2,4- triazolo(1,5- c)pyrimidineIBA
12/2009
1Probenecid (Benemid)FDA LinkGeneric
03/2009
1PPAR gammaIBA
03/2009
1Rosiglitazone (Avandia)FDA Link
03/2009

Therapy/Procedure

1Traditional Medicine (Folk Remedies)
02/2009
1Therapeutics
07/2007